Riskpilot← Back to searchSign inGet full accessBJERGSTED KLINIKKEN AS
ASActiveOrg 990370036Sverdrups gate 23, 4007 StavangerPhysiotherapy activities · NACE 8695Est. 20060 employees
Revenue 2025
NOK 509K
+6% vs 2024
EBITDA margin
30.2%
+203% vs 2024
Equity ratio
96.9%
Financial strength
Net profit 2025
NOK 104K
+335% vs 2024
| Revenue | NOK 509K | +6% |
| EBITDA | NOK 154K | +203% |
| Net profit | NOK 104K | +335% |
| Total assets | NOK 366K | +43% |
| Equity | NOK 355K | +42% |
| Employees | 0 | — |
Legal name
BJERGSTED KLINIKKEN AS
Org number
990370036
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
16. oktober 2006
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Helsetjenester, fysioterapitjenester, konsulentvirksomhet, salg og utleie av fast eiendom, forretningsvirksomhet som handel og kjøp. Selskapet kan ved deltakelse eller ved aksjekjøp også gjøre seg interessert i andre foretagender og virksomhet.
Address
Sverdrups gate 23, 4007 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 428 | 446 | 470 | 478 | 509 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 32 | 2 | −89 | 51 | 154 |
| Depreciation & amort. | −35 | −20 | −20 | −20 | −20 |
| EBIT | −3 | −18 | −110 | 31 | 134 |
| Net financials | 0 | −0 | −0 | 0 | 0 |
| Profit before tax | −3 | −18 | −110 | 31 | 134 |
| Tax | −1 | −4 | −24 | 7 | 29 |
| Net profit | −3 | −14 | −86 | 24 | 104 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 327 | 307 | 227 | 257 | 366 |
| Equity | 326 | 313 | 227 | 251 | 355 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | −6 | 0 | 6 | 11 |
| Total debt | 0 | −6 | 0 | 6 | 11 |
EBITDA margin
30.2%
This company
15.8%
Market median
+91% vs market
20212025
Equity ratio
96.9%
This company
38.2%
Market median
+154% vs market
20212025
Return on equity
29.3%
This company
18.4%
Market median
+59% vs market
20212025
Net profit margin
20.5%
This company
8.1%
Market median
+153% vs market
20212025
Asset turnover
1.39×
This company
1.12×
Market median
+24% vs market
20212025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TE Deputy Member | Deputy Member | 2007 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2007 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BJERGSTED KLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Trond Eltervaag | Deputy Member | 0 companies |
| Ragnhild Elise Nymoen Kuru Eltervaag | Chairman | 0 companies |